Bullish Options Activity in Teva Pharma (TEVA) Continues -Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St set for higher open but weekly losses loom
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Merck (MRK) Wins Bid to Revive NuvaRing Patent Case Against Teva (TEVA) - Bloomberg
October 19, 2017 10:18 AM EDTMerck (NYSE: MRK) won a bid to revive a NuvaRing patent case against Teva Pharma (NYSE: TEVA), according to Bloomberg. A federal judge erred in ruling the patent for vaginal ring is invalid, said the U.S. Court of Appeals for the Federal Circuit in an opinion.
... More